Onureg (azacitidine oral) - BMS
Vyxeos (cytarabine/daunorubicin liposomal formulation) - Jazz
Oral Azacitidine Maintenance After CPX-351 in Transplant-Ineligible Patients With Therapy-Related or Myelodysplasia-Related Acute Myeloid Leukemia. (PubMed, Am J Hematol) - Oct 10, 2026 - No abstract available 
Journal • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42855426
 
A H Wei; Alexander Coltoff; Caroline Fileni; Christoph Röllig; David Sallman; David Swoboda; Edmond Chiche; Fabio Guolo; Geoffrey Uy; Jeffrey Lancet; Lenaïg Le Clech; Ludovic Gabellier; Lydia Kretschmer; Maël Heiblig; Patrick Lawrence; Rami Komrokji; Roberto Massimo Lemoli; Sarah Bertoli; Thomas Cluzeau
 
Oct 10, 2026
 
Prev Next